Is Lo Loestrin Fe or Yasmin safer regarding blood clot risks for women over thirty-five with mild seasonal allergies?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Is Lo Loestrin Fe or Yasmin safer regarding blood clot risks for women over thirty-five with mild seasonal allergies?
3 real searches · 1 real-search pass
Lo Loestrin Fe prescribing information venous thromboembolism risk norethindrone acetate ethinyl estradiol 10 mcg FDA labelGoogle ↗
OBSERVEDConsequence
Yasmin prescribing information venous thromboembolism drospirenone risk compared norethindrone FDA labelGoogle ↗
OBSERVEDComparison
CDC U.S. Medical Eligibility Criteria combined hormonal contraception age 35 smoking venous thromboembolism 2024Google ↗
OBSERVEDConsequence
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
ChatGPT real searches (3)
Classes come from the query-classifier (a local Laya model). 3 of 3 calls are low-confidence (under 50%) — hover a query in the table to see its confidence.
Searches and sources
ChatGPT3 real searches · gpt-6
Lo Loestrin Fe prescribing information venous thromboembolism risk norethindrone acetate ethinyl estradiol 10 mcg FDA label Google ↗
Yasmin prescribing information venous thromboembolism drospirenone risk compared norethindrone FDA label Google ↗
CDC U.S. Medical Eligibility Criteria combined hormonal contraception age 35 smoking venous thromboembolism 2024 Google ↗
- DailyMed - These highlights do not include all the information needed to use Lo Loestrin Fe safely and effectively. See full prescribing information for Lo Loestrin Fe. Lo Loestrin ® Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets) Initial U.S. Approval: 1968 · dailymed.nlm.nih.gov
- label · accessdata.fda.gov
- U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 · cdc.gov
- Appendices for U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 · cdc.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
Lo Loestrin Fe prescribing information venous thromboembolism risk norethindrone acetate ethinyl estradiol 10 mcg FDA label OBSERVED | Google ↗ AI Mode ↗ | — | Consequence | — | — | 1x of 1 | |
Yasmin prescribing information venous thromboembolism drospirenone risk compared norethindrone FDA label OBSERVED | Google ↗ AI Mode ↗ | — | Comparison | — | — | 1x of 1 | |
CDC U.S. Medical Eligibility Criteria combined hormonal contraception age 35 smoking venous thromboembolism 2024 OBSERVED | Google ↗ AI Mode ↗ | — | Consequence | — | — | 1x of 1 |